Progyny Inc PGNY

$28.97 -0.15 (-0.52%)

Valuation

Market cap
2,222,781,000
Revenue TTM
$1,288,660,000
Net income TTM
$58,520,000
PE ratio
31.65
Forward PE
23.30
Profit margin
4.54%
Debt to equity
0.00

Trading

Volume
565,800
Avg volume
1,081,302
Day's range
$28.80 – $29.11
Shares out
76,727,000
Stochastic %K
89%
Beta
1.02
Analysts
Strong Sell
Price target
$34.00

Price

Company profile

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integr...

Show more

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Industry
Healthcare Plans
Sector
Healthcare
Phone
212 888 3124
Website
https://www.progyny.com
Address
1359 Broadway, New York, United States

Latest news

Stocktwits

commonking Oct 20, 3:35 PM
$PGNY Hello old friend...
0 replies
BioTechHealthX Oct 17, 3:53 PM
$PGNY Progyny, Inc. (NASDAQ: PGNY) generated $50.4 million in quarterly operating cash flow. Explore whether its fertility benefits business can accelerate revenue growth. https://biotechhealthx.com/biotech-news/progyny-pgny-generates-50-4m-in-quarterly-cash-flow/
0 replies
BullMeetsWorld Oct 13, 2:55 PM
$PGNY she's ready to go back to 30+
0 replies
Tickrtrends Oct 8, 4:15 PM
$PGNY screened as undervalued in this week's run. It has since closed 5 or more percentage points of the gap to our fair value estimate and remains more than 25% below it. Progyny carries P/E trailing 18x alongside Debt/equity 0.06. For information only; this is not investment advice. Always do your own research. https://stocks.tickrtrends.com/pgny?utm_source=dlvr.it&utm_medium=stocktwits
0 replies
USMC0321VET Oct 5, 10:58 AM
$PGNY I've few times traded this. I was profitable. Is it going up from here? Is it time I buy back in? Someone tell me why they hold this. On RH, of 12 analyst ratings, 10 say to buy, 2 say hold, 0 say sell. The one time I followed RH analyst advice, the stock doubled. Anyone think that could happen here?
1 replies
Lotsofdollars Sep 25, 1:58 PM
$PGNY I really hate this stock. Each f*ING day no volumes because the big players just sit and watch. I am forced to keep. This is the bottom anyway. So go to do sth else let me know when it reaches 30.
0 replies
txbondman Sep 25, 1:56 PM
bot $PGNY to double down; (Don't try this at home!!)
0 replies
roblake29 Sep 18, 7:38 PM
$PGNY I continue to rate Progyny a buy. Read why here: https://seekingalpha.com/article/4947525-progyny-best-in-class-and-likely-to-exceed-analyst-estimates-in-2027
0 replies